Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain: Complete Statistical AnalysisIndependent statistical analysis of Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain: primary endpoint results, effect estimate with confidence interval, sample-size…
- Glottic View Using Supraglottic Devices in Pediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Glottic View Using Supraglottic Devices in Pediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02532465).
- GLOWIndependent statistical analysis of the phase 3 GLOW trial of zolbetuximab plus CAPOX versus placebo plus CAPOX in CLDN 18.2-positive, HER2-negative gastric or gastroesophageal junction adenocarcinoma, including time-to-event methodology, reported efficacy results,…
- GLOW7Independent statistical analysis of Efficacy, Safety and Tolerability of NVA237 in Patients With Chronic Obstructive Pulmonary Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight: Complete Statistical AnalysisIndependent statistical analysis of GLP-1 Analogue Effects on Food Cues, Stress, Motivation for Highly Palatable Foods, and Weight: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response: Complete Statistical AnalysisIndependent statistical analysis of GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19): Complete Statistical AnalysisIndependent statistical analysis of GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- GLS-5700 in Dengue Virus-Naïve Adults: Complete Statistical AnalysisIndependent statistical analysis of GLS-5700 in Dengue Virus-Naïve Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02809443).
- Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Glucagon Response to Prandial Insulin Administration in Persons With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Glucagon Use in Colonoscopies: Complete Statistical AnalysisIndependent statistical analysis of Glucagon Use in Colonoscopies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02078726).
- Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism: Complete Statistical AnalysisIndependent statistical analysis of Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Glucophage Extended Release (GXR) China Bioequivalence Study (Nantong – Darmstadt): Complete Statistical AnalysisIndependent statistical analysis of Glucophage Extended Release (GXR) China Bioequivalence Study (Nantong - Darmstadt): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03566810).
- Glucose Counterregulation in Long Standing Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Glucose Counterregulation in Long Standing Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01474889).
- Glucose Regulation in Acute Stroke Patients (GRASP) Study: Complete Statistical AnalysisIndependent statistical analysis of Glucose Regulation in Acute Stroke Patients (GRASP) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00282867).
- Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients: Complete Statistical AnalysisIndependent statistical analysis of Glucose Response of G-Pen (Glucagon Injection) in Pediatric T1D Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03091673).
- Glucose Variability in Type 1 Diabetes (T1D) and Glycaemic Responses to Food Composition.: Complete Statistical AnalysisIndependent statistical analysis of Glucose Variability in Type 1 Diabetes (T1D) and Glycaemic Responses to Food Composition.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- GlulipidIndependent statistical analysis of Glucose and Lipid Metabolism on Antipsychotic Medication: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00515723).
- GLUMIT-DGIndependent statistical analysis of Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01030341).
- Glutamate Reducing Interventions in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Glutamate Reducing Interventions in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03321617).
- GLUTAMICSIndependent statistical analysis of Glutamate for Metabolic Intervention in Coronary Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00489827).
- Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy: Complete Statistical AnalysisIndependent statistical analysis of Glutamine for the Prevention of Radiation Toxicity in Subjects Conserving Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Glutamine in Preventing Myalgia and/or Arthralgia in Patients Who Are Receiving Paclitaxel For Cancer: Complete Statistical AnalysisIndependent statistical analysis of Glutamine in Preventing Myalgia and/or Arthralgia in Patients Who Are Receiving Paclitaxel For Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Glutamine Therapy for Hemolysis-Associated Pulmonary Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01048905).
- Glutathione and Function in HIV Patients: Complete Statistical AnalysisIndependent statistical analysis of Glutathione and Function in HIV Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02348775).
- Glutathione Metabolism in Adolescents With Type 1 Diabetes – Study A: Complete Statistical AnalysisIndependent statistical analysis of Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Glycemia in Diabetic Elders Trial: Complete Statistical AnalysisIndependent statistical analysis of Glycemia in Diabetic Elders Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02029846).
- Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery: Complete Statistical AnalysisIndependent statistical analysis of Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00328094).
- Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment: Complete Statistical AnalysisIndependent statistical analysis of Glycemic Efficacy and Renal Safety Study of Dapagliflozin in Subjects With Type 2 Diabetes Mellitus and Moderate Renal Impairment: primary endpoint results, effect estimate with confidence interval, sample-size…
- Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD: Complete Statistical AnalysisIndependent statistical analysis of Glycopyrronium and Formoterol Fumarate (GFF) Metered Dose Inhaler (MDI) Dose Indicator Study in Adults With Moderate to Very Severe COPD: primary endpoint results, effect estimate with confidence interval,…
- GLYCOSA Study:Effect of PAP Treatment on Glycemic Control in Patients With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of GLYCOSA Study:Effect of PAP Treatment on Glycemic Control in Patients With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- GMRTIndependent statistical analysis of Gomco Versus Mogen: Which is Best? A Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01726036).
- GMRx2_PCTIndependent statistical analysis of Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- GMTIndependent statistical analysis of Neonatal Gastro-Esophageal Reflux Disease (GERD) Management Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02486263).
- GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC: Complete Statistical AnalysisIndependent statistical analysis of GNOS-PV02 Personalized Neoantigen Vaccine, INO-9012 and Pembrolizumab in Subjects With Advanced HCC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- GO-COLITISIndependent statistical analysis of Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02092285).
- GO-VIVAIndependent statistical analysis of A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy: primary endpoint results,…
- GO2 PEEPIndependent statistical analysis of Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- GOALIndependent statistical analysis of Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- GOALSIndependent statistical analysis of Gaining Optimism After Weight Loss Surgery (GOALS) II: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04868032).
- Goblet Cell Degranulation Produced by Intranasal Tear Neurostimulator (ITN) in Dry Eye Disease: Complete Statistical AnalysisIndependent statistical analysis of Goblet Cell Degranulation Produced by Intranasal Tear Neurostimulator (ITN) in Dry Eye Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- GOCIndependent statistical analysis of Goals of Care: A Nursing Home Trial of Decision Support for Advanced Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- GOLDEN-3Independent statistical analysis of Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA): Complete Statistical AnalysisIndependent statistical analysis of Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- GOLMePsAIndependent statistical analysis of GOLimumab and Methotrexate Versus Methotrexate in Very Early PsA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04108468).
- GonoScreenIndependent statistical analysis of GonoScreen: Efficacy of Screening STIs in MSM: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04269434).
- GORE® TAG® Thoracic Endoprosthesis French Mandatory Registry: Complete Statistical AnalysisIndependent statistical analysis of GORE® TAG® Thoracic Endoprosthesis French Mandatory Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02266342).
- GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03): Complete Statistical AnalysisIndependent statistical analysis of GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04706273).
- Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery: Complete Statistical AnalysisIndependent statistical analysis of Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery: primary endpoint results, effect estimate with confidence interval, sample-size…